Fig. 8From: Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell deathA schematic diagram shows the mode of action of Amy on the HepG2 cell line. Treatment of the HepG2 cell line with Amy resulted in potential cytotoxicity, and significant down-regulation for the AMPK/mTOR/BCL-2 pathway, with induction of apoptosis and autophagy by extrinsic and intrinsic pathwaysBack to article page